Ando M - Search Results

1

Phase II study of carboplatin, docetaxel and bevacizumab for chemotherapy-naïve patients with advanced non-squamous non-small cell lung cancer.

Takiguchi Y, Iwasawa S, Minato K, Miura Y, Gemma A, Noro R, Yoshimori K, Shingyoji M, Hino M, Ando M, Okamoto H. Takiguchi Y, et al. Among authors: ando m. Int J Clin Oncol. 2015 Aug;20(4):659-67. doi: 10.1007/s10147-014-0755-6. Epub 2014 Oct 11. Int J Clin Oncol. 2015. PMID: 25301566 Clinical Trial.

2

Weekly administration of irinotecan (CPT-11) plus cisplatin for refractory or relapsed small cell lung cancer.

Ando M, Kobayashi K, Yoshimura A, Kurimoto F, Seike M, Nara M, Moriyama G, Mizutani H, Hibino S, Gemma A, Okano T, Shibuya M, Kudoh S. Ando M, et al. Lung Cancer. 2004 Apr;44(1):121-7. doi: 10.1016/j.lungcan.2003.10.003. Lung Cancer. 2004. PMID: 15013590 Clinical Trial.

3

E-cadherin expression and epidermal growth factor receptor mutation status predict outcome in non-small cell lung cancer patients treated with gefitinib.

Miyanaga A, Gemma A, Ando M, Kosaihira S, Noro R, Minegishi Y, Kataoka K, Nara M, Okano T, Miyazawa H, Tanaka T, Yoshimura A, Kobayashi K, Iwanami H, Hagiwara K, Tsuboi E, Kudoh S. Miyanaga A, et al. Among authors: ando m. Oncol Rep. 2008 Feb;19(2):377-83. Oncol Rep. 2008. PMID: 18202784

4

First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy.

Inoue A, Kobayashi K, Usui K, Maemondo M, Okinaga S, Mikami I, Ando M, Yamazaki K, Saijo Y, Gemma A, Miyazawa H, Tanaka T, Ikebuchi K, Nukiwa T, Morita S, Hagiwara K; North East Japan Gefitinib Study Group. Inoue A, et al. Among authors: ando m. J Clin Oncol. 2009 Mar 20;27(9):1394-400. doi: 10.1200/JCO.2008.18.7658. Epub 2009 Feb 17. J Clin Oncol. 2009. PMID: 19224850 Clinical Trial.

5

Exacerbation of idiopathic interstitial pneumonias associated with lung cancer therapy.

Minegishi Y, Takenaka K, Mizutani H, Sudoh J, Noro R, Okano T, Azuma A, Yoshimura A, Ando M, Tsuboi E, Kudoh S, Gemma A. Minegishi Y, et al. Among authors: ando m. Intern Med. 2009;48(9):665-72. doi: 10.2169/internalmedicine.48.1650. Epub 2009 May 1. Intern Med. 2009. PMID: 19420811 Free article.

6

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR.

Maemondo M, Inoue A, Kobayashi K, Sugawara S, Oizumi S, Isobe H, Gemma A, Harada M, Yoshizawa H, Kinoshita I, Fujita Y, Okinaga S, Hirano H, Yoshimori K, Harada T, Ogura T, Ando M, Miyazawa H, Tanaka T, Saijo Y, Hagiwara K, Morita S, Nukiwa T; North-East Japan Study Group. Maemondo M, et al. Among authors: ando m. N Engl J Med. 2010 Jun 24;362(25):2380-8. doi: 10.1056/NEJMoa0909530. N Engl J Med. 2010. PMID: 20573926 Free article. Clinical Trial.

7

Phase I study of topotecan and cisplatin in patients with small cell lung cancer.

Ichinose Y, Seto T, Nishiwaki Y, Kiura K, Sakai H, Yokoyama A, Segawa Y, Ando M, Watanabe K. Ichinose Y, et al. Among authors: ando m. Jpn J Clin Oncol. 2011 Feb;41(2):197-203. doi: 10.1093/jjco/hyq177. Epub 2010 Oct 11. Jpn J Clin Oncol. 2011. PMID: 20937601 Clinical Trial.

8

Phase II study of topotecan with cisplatin in Japanese patients with small cell lung cancer.

Hosomi Y, Shibuya M, Niho S, Ichinose Y, Kiura K, Sakai H, Takeda K, Kudo S, Eguchi K, Matsui K, Masuda N, Ando M, Watanabe K. Hosomi Y, et al. Among authors: ando m. Anticancer Res. 2011 Oct;31(10):3449-56. Anticancer Res. 2011. PMID: 21965760 Clinical Trial.

9

Combination chemotherapy of alternating etoposide and carboplatin with weekly administration of irinotecan and cisplatin in extensive-stage small-cell lung cancer.

Yoshimura A, Noro R, Miyanaga A, Mizutani H, Kosaihira S, Minegishi Y, Seike M, Hino M, Ando M, Nomura K, Okano T, Kobayashi K, Gemma A; East Japan Chesters Group. Yoshimura A, et al. Among authors: ando m. Anticancer Res. 2012 Oct;32(10):4473-8. Anticancer Res. 2012. PMID: 23060575 Clinical Trial.

10

Bevacizumab plus chemotherapy for advanced non-squamous non-small-cell lung cancer with malignant pleural effusion.

Kitamura K, Kubota K, Ando M, Takahashi S, Nishijima N, Sugano T, Toyokawa M, Miwa K, Kosaihira S, Noro R, Minegishi Y, Seike M, Yoshimura A, Gemma A. Kitamura K, et al. Among authors: ando m. Cancer Chemother Pharmacol. 2013 Feb;71(2):457-61. doi: 10.1007/s00280-012-2026-4. Epub 2012 Nov 21. Cancer Chemother Pharmacol. 2013. PMID: 23178954

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,487 results

Search Page

Filters